Clinical Applicability of PBSCIMMO as a Single Material in Endodontic Obturations

NCT ID: NCT03514264

Last Updated: 2018-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-09

Study Completion Date

2019-02-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized, interventional, prospective, unicentric clinical study, 86 patients will be submitted to endodontic treatment of necrotic teeth. 43 patients will complete treatment with obturation with AHPlus cement and Gutta-Percha cones (group A) and 43 patients will complete treatment with PBS® CIMMO cement (single material) (group B). The primary outcome will be the repair of the periradicular lesion demonstrated by integrity of the hard blade throughout the perimeter of the root identified by Tomography Cone Beam, performed after 6 months of treatment. The secondary endpoint will be the absence of fistula after 6 months of treatment identified by clinical examination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GOALS PRIMARY OBJECTIVE-Evaluate the PBS CIMMO cement as a single element in endodontic obturations of necrotic teeth, through the analysis of integrity of the hard blade throughout the perimeter of the root of the treated tooth, identified by Tomography Cone Beam, after 6 months of treatment.

SECONDARY OBJECTIVE- Clinical evaluation of teeth treated after 6 months, with the purpose of identifying the absence of clinical signs and symptoms, through the finding of absence of fistula.

METHOD-DESIGN A randomized, interventional, prospective, unicentric, double blind clinical trial.

APPROVAL This work was approved by the Research Ethics Committee of the Vale do Sapucaí University (UNIVÁS) and is registered in the Brazilian Platform - Certificate of Approval for CAAE-number 77495717.7.0000.5102 CONSENT Relevant information from this study will be provided to all patients in an understandable way. Patients will have the opportunity to have their questions answered and will provide their consent by signing the free and informed consent form The study is being carried out in Brazil, in the urban area of the city of Pouso Alegre, state of Minas Geraes, in the Clinic of the Brazilian Association of Dentistry (ABO).

Interventions

The recommended techniques will be different for each group. GROUP A - CUTTING WITH CEMENT AHPLUS AND GUTTA HANGER

1. First session

Intra-channel medication and instrumentation procedures:

Local anesthesia with lidocaine and phenylephrine 1: 100,000 (DFL® Industry and Commerce-Brazil) will be used a tube containing 1.8 ml. Absolute insulation with clamp W8A and 8ª (SSWhite ® -Duflex-Brasil), rubber sheet (Madeitex®-Brazil) and arch (JON® Brazil). The opening will be performed with a high-speed motor (Dabi Atlante® Equipamentos Odontológicos Brasil), low rotation (Dabi Atlante®) and endodontic probe (Duflex®) drill 1016 HL (KG®-Sorensen). Mechanized instrumentation will be carried out using the Endo Easy SI® motor in reciprocating module. The endodontic instrument for instrumentation will be the Logic Easy® file numbering (2505). Pre-crown-down instrumentation will be performed on the cervical, middle and apical thirds, with apparent measurements determined by the initial radiograph. Each channel will receive irrigation with 2.5% sodium hypochlorite through a 10ml disposable syringe with a 0.55x20 24G hypodermic needle. 3/4 SR®. Then, the localization of the foramen with Novapex® foramen locator will be performed and the working length will be determined and then instrumentation with the same file will be determined. Through a reciprocating Easy Clean® device, PUI (Passive Ultrasonic Irrigation) with ethylene diamino tetraacetic acid, surfactant (EDTA T) Formula \& Action® as well as sodium hypochlorite will be performed. Then, it will be installed in the channels, Callen PMCC SSWhite® (Calcium hydroxide paste with camphorated paramonoclorophenol) MIC (intra-canal medication) to perform disinfection of dentinal canaliculi. Such paste will temporarily seal these channels for 4 weeks.
2. Second session -After 30 days The obturation with AHPlus cement and Gutta Percha (group A) will be performed in 43 teeth, according to the following sequence: test of the main gutta percha Dentsply®, after foramen calibration. Handling of the AH Plus Dentsply® cement will be carried out. The medium cone will be greased with cement and taken to the canal. Through an Easy-Compressor term, the cone will be cut and compacted "hot" in the channel. New cone will be placed in the space conquered by compaction, will be cut "hot" by term compactor and then condensed by condenser instrument Schilder Oddus De Deus®. Soon after, the teeth will be restored with Charisma Kulzer® photopolymerizable resin, Radi® light curing. Patients will be submitted to final radiographs and receive systemic medication with analgesic Lisador® 1 tablet every 6 hours while there is pain. The recommended anti-inflammatory will be Decadron 4mg, 1 tablet every 12 hours for 3 days, if the patient can not use it, Maxulid 400 mg, 1 tablet every 12 hours for 3 days will be given. The antibiotic of choice will be Sinot Clav® 875 mg, 1 tablet every 12 hours for 7 days. In case of allergy to Amoxicillin, Dalacin 300 mg, 1 capsule every 8 hours for 7 days will be given. After 6 months, the patients will return to the Clinic of the Brazilian Association of Dentistry to perform a Cone Beam CT scan and clinical examination.

GROUP B - CUTTING WITH PBSCIMMO CEMENT SINGLE SESSION Instrumentation and filling procedures Local anesthesia with lidocaine and phenylephrine 1: 100,000 (DFL® Industry and Commerce-Brazil) will be used a tube containing 1.8 ml. Absolute insulation with clamp W8A and 8ª (SSWhite ® -Duflex-Brasil), rubber sheet (Madeitex®-Brazil) and arch (JON® Brazil). The opening will be performed with a high-speed motor (Dabi Atlante® Equipamentos Odontológicos Brasil), low rotation (Dabi Atlante®) and endodontic probe (Duflex®) drill 1016 HL (KG®-Sorensen). Mechanized instrumentation will be carried out using the Endo Easy SI® motor in reciprocating module. The endodontic instrument for instrumentation will be the Logic Easy® file numbering (2505). Pre-crown-down instrumentation will be performed on the cervical, middle and apical thirds, with apparent, determined by the initial radiography. Each channel will receive irrigation with 2.5% sodium hypochlorite through a 10ml disposable syringe with a 0.55x20 24G hypodermic needle. 3/4 SR®. Then, the localization of the foramen with Novapex® foramen locator will be performed and the working length will be determined and then instrumentation with the same file will be determined. Through a reciprocating Easy Clean® device, PUI (Passive Ultrasonic Irrigation) with ethylene diamino tetraacetic acid, surfactant (EDTA T) Formula \& Action® as well as sodium hypochlorite will be performed. Continuously, the PBS CIMMO® cement will be installed in the channels, as a single obturator element. The CBS® PBS Cement seal (Group B) will be made of 43 teeth as follows: the instruments used will be the number 40 nickel and titanium Macspaden Flex Pack® micro-motor capacitors coupled to the internal dental office system and nickel and titanium in numbers and standard colors: Green (0.35 and 0.70), Black (0.40 and 0.80), Yellow (0.50 and 1.00), Blue (0.60 and 1.20). Handling of CIMMO® PBS cement will follow manufacturer's recommendations: on sterile glass plate, a portion of the cement powder and a drop of distilled water will be dispensed. Through a flexible spatula, the powder will be mixed to the liquid and spatulate until the consistency of toothpaste. The Macspaden Flex Pack® 40 instrument will then be coupled to the micro-motor and embedded in cement. When it is taken to the channel, the micro-motor will be activated and the channel will be in and out. Then, condensation will occur with the green condenser tip thinner and then thicker. In the same way, more cement will be brought to the channel with Flex Pack® number 40 and again condensed now with the black, thin point and then thick capacitors. These maneuvers will be repeated until the fine and thick blue capacitors are used and the absence of spaces is verified. Soon after, the teeth will be restored with Charisma Kulzer® photopolymerizable resin, Radi® light curing. Patients will be submitted to final radiographs and receive systemic medication with analgesic Lisador® 1 tablet every 6 hours while there is pain. The recommended anti-inflammatory will be Decadron®, 4mg, 1 tablet every 12 hours for 3 days, if the patient is unable to use it, Maxulid® 400mg, 1 tablet every 12 hours for 3 days will be given. The antibiotic of choice will be Sinot Clav® 875 mg, 1 tablet every 12 hours for 7 days. In case of allergy to Amoxicillin, Dalacin 300 mg, 1 capsule every 8 hours for 7 days will be given. After 6 months, the patients will return to the Clinic of the Associação Brasileira de Odontologia to perform a Cone Beam tomografy scan and clinical examination.

Sample size: 86 patients The observed response will be dichotomous, the type of analysis will be by comparing two proportions. The investigators accessed the site www.lee.dante.br 25, Lee-Samples for verification of possible identification of n. The proportions were based on the literature.

Proportion in group 1: 36% Proportion in group 2: 10% Level of significance: 5% Power of the test: 90% Hypothesis test: monocaudal Sample size calculated for each group: 43

Allocation: Patients are allocated to the study or control group in a 1: 1 ratio using a software-generated randomizer - RANDOMIZATION.COM (http://www.randomization.com)26. Concealment Mechanism: Opaque, sealed and serial number envelopes containing the group as well as the material to be used will be used to maintain the confidentiality of the random allocation. The envelopes will be delivered to the professional who performed the intervention at the initial moment Patients will not know which research group will participate. After 6 months, a CT scan and clinical examination will be performed. The evaluations will be performed by professionals who did not participate in the intervention and have more than 20 years of experience in endodontics. These professionals will not know to which group the patient belongs.

Recruitment of patients-waiting list of patients who seek the clinic of the Associação Brasileira de Odontologia (ABO) -UNIVÁS.

Beginning of appointments: November 2017 Data collection: June 2018.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Root Canal Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A randomized, interventional, prospective, unicentric, double blind clinical trial.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
After 6 months the results will be evaluated by two independent professionals, who did not participate in the interventions and are not aware of the allocation. The evaluation will be performed by means of tomography and clinical examination

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GUTTA PERCHA and AHPLUS cement (group A)

43 patients will undergo endodontic treatment with obturation with AHPlus cement and Gutta-Percha cones. This treatment will be performed in 2 sessions. First intervention: endodontic instrumentation and introduction of intra-canal medication that will remain in the tooth for 4 weeks. Second intervention: removal of intracanal medication and filling with cement and gutta percha AHPlus.

Group Type EXPERIMENTAL

Gutta Percha and AHPLUS cement (group A)

Intervention Type PROCEDURE

First intervention: endodontic instrumentation and introduction of intact medication that will remain inside the tooth for 4 weeks.

Second intervention: removal of intracanal medication and canal filling with cement AHPLUS and guttapercha

PBS CIMMO cement (group B)

43 patients will undergo endodontic treatment with PBS CIMMO® cement (single material).This treatment will be performed in 1 session.Single intervention: endodontic instrumentation and cement filling PBS CIMMO.

Group Type EXPERIMENTAL

PBS CIMMO cement (group B)

Intervention Type PROCEDURE

Single intervention: endodontic instrumentation and obturation with cement PBS CIMMO

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gutta Percha and AHPLUS cement (group A)

First intervention: endodontic instrumentation and introduction of intact medication that will remain inside the tooth for 4 weeks.

Second intervention: removal of intracanal medication and canal filling with cement AHPLUS and guttapercha

Intervention Type PROCEDURE

PBS CIMMO cement (group B)

Single intervention: endodontic instrumentation and obturation with cement PBS CIMMO

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients presenting with a diagnosis of necrosis.

Exclusion Criteria

* Patients who drop out during the study
* Patients who do not return to the final exam after 6 months.
* Patients who present more than one tooth in need of treatment will choose only one tooth, the others will be excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade do Vale do Sapucai

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rubia Moura Leite Boczar

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rubia Boczar

Role: PRINCIPAL_INVESTIGATOR

Univás-Universidade do Vale do Sapucaí- Pouso Alegre Minas Geraes

Taylor b Schnaider, MD,PhD

Role: STUDY_DIRECTOR

Universidade Vale do Sapucaí

Daniela F Veiga, MD,PhD

Role: STUDY_CHAIR

Universidade Vale do Sapucaí

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rubia Moura Leite Boczar

Pouso Alegre, Minas Gerais, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.